Orexo Announces FDA Acceptance Of Investigational New Drug Application
Orexo AB OMXSTO:ORX
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Orexo Announces FDA Acceptance of Investigational New Drug (IND) Application for OX640 for the Treatment of Anaphylaxis
Uppsala, Sweden — September 14th 2026 — Orexo AB (publ.) (STO:ORX) (OTCQX:ORXOY) today announces that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OX640, a nasally administered powder formulation of epinephrine intended for the emergenc…